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ABSTRACT
MicroRNAs (miRNAs) are short non-coding RNAs
that play a central role in regulation of gene expres-
sion by binding to target genes. Many miRNAs
were associated with the function of the central
nervous system (CNS) in health and disease.
Astrocytes are the CNS most abundant glia cells,
providing support by maintaining homeostasis and
by regulating neuronal signaling, survival and
synaptic plasticity. Astrocytes play a key role in
repair of brain insults, as part of local immune
reactivity triggered by inflammatory or patho-
logical conditions. Thus, astrocyte activation, or
astrogliosis, is an important outcome of the innate
immune response, which can be elicited by endo-
toxins such as lipopolysaccharide (LPS) and
cytokines such as interferon-gamma (IFN-c). The
involvement of miRNAs in inflammation and stress
led us to hypothesize that astrogliosis is mediated
by miRNA function. In this study, we compared the
miRNA regulatory layer expressed in primary
cultured astrocyte derived from rodents (mice)
and primates (marmosets) brains upon exposure
to LPS and IFN-c. We identified subsets of differen-
tially expressed miRNAs some of which are shared
with other immunological related systems while
others, surprisingly, are mouse and rat specific. Of
interest, these specific miRNAs regulate genes
involved in the tumor necrosis factor-alpha (TNF-a)
signaling pathway, indicating a miRNA-based
species-specific regulation. Our data suggests that
miRNA function is more significant in the mechan-
isms governing astrocyte activation in rodents
compared to primates.
INTRODUCTION
Astrocytes, referring to heterogeneous population of cells,
are the most abundant glial cells in the central nervous
system (CNS). They are involved in a variety of CNS
functions as they form structural support to the brain,
maintain CNS homeostasis, regulate neuronal signaling,
survival and synaptic plasticity by releasing neurotrophic
factors and regulating neurotransmitter metabolism.
Astrocytes also participate in the formation of the
blood–brain barrier (BBB), as they are in juxtaposition
to both neurons and blood vessels. The role of astrocytes
in local immune reactivity, however, has long been neg-
lected. In response to inﬂammatory or other pathological
conditions, astrocytes leave their quiescent state and
become activated. These activated astrocytes are termed
reactive astrocytes and the process itself is known as
astrogliosis. The purpose of astrogliosis is to contribute
to brain repair by isolation of the damaged area and by
reconstitution of the BBB. Furthermore, astrogliosis
repairs neuron circuits by stimulating axon growth and
synaptogenesis in areas distal from the site of initial
insult and by forming a non-permissive scar, preventing
axon growth into the damaged regions (1). Inﬂammation
can be triggered by signals of bacterial infection such as
the endotoxin lipopolysaccharide (LPS) that is found in
the outer-membrane of Gram-negative bacteria. LPS was
shown to induce the expression and secretion of
chemokine and proinﬂammatory cytokine such as
interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a)
and interleukin-1b (IL-1b) from astrocytes (2). In the
brain, this effect is a global outcome of an intensive
cross-talk between astrocytes, microglia and inﬁltrating
peripheral immune cells which interact and facilitate the
response in an autocrine/paracrine manner. This results in
cytokine and chemokine secretion by astrocytes together
with induction of processing and presentation of antigens
against Th1, Th2, and naive CD4
+ T cells (2,3).
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non-coding RNAs that guide post-transcriptional repres-
sion of protein-coding genes by base-pairing with the 30
untranslated region (30 UTR) of target mRNAs. The
miRNA regulatory site is the ‘seed’ region, comprising
bases 2–8 from the miRNA’s 50 end (4), mostly directing
full complementation with mRNAs. miRNAs have been
extensively investigated in the past few years and over
17000 miRNAs are now reported, in 142 species,
including over 1000 in human [miRBase (5)]. In verte-
brates each miRNA is estimated to target several
hundred transcripts (6), leading to target mRNA degrad-
ation and/or translation inhibition (7), and more than
60% of protein-coding genes are predicted to undergo
direct miRNA regulation (8). In some cases, miRNAs
were shown to deﬁne global tissue-speciﬁc mRNA levels
(9), while the overall protein output level is consequently
adjusted (10,11).
The complexity of brain tissue requires intricate regula-
tion over the expression levels of numerous genes.
miRNAs play a signiﬁcant role in this regulation. Sixty
percent of the known miRNAs are expressed in the
brain, while some of those enriched or unique for
neuronal tissues (12). Most miRNA research of the
nervous system has focused on development, in general,
or on patterning and cell speciﬁcation, in particular (13).
The most abundant and well-studied CNS miRNA is
miR-124 which plays a role in neuronal differentiation
(9,14). miRNAs are recognized as vital regulators in
immunity and inﬂammation (15,16). Human astrocyte
miRNAs, identiﬁed by proﬁling of multiple sclerosis
lesions, include the well-established immune response
miRNA—miR-155—which is regulated by several cyto-
kines (17) while the inﬂammation-associated miR-146a
was upregulated in activated astrocytes of temporal lobe
epilepsy (TLE) (18).
In the current study, we present a miRNA expression
analysis during astrocyte activation by LPS and IFN-g.
The analysis of the differentially expressed miRNAs
leads us to subsets of miRNAs, some of which are
shared with other immunological related systems in mice
and human while others, surprisingly, are mouse and rat-
speciﬁc. Of special interest are the mouse and rat-speciﬁc
miR-351 and miR-298, which regulate genes involved in
the TNF-a signaling pathway, indicating a miRNA-based
species-speciﬁc regulation. Altogether, our data suggests
that miRNA function holds a more fundamental role in
the mechanisms governing astrocyte activation in rodents
compared to primates.
MATERIALS AND METHODS
Ethics statement
All experimental procedures involving mice were approved
by the Tel Aviv University Animal Care Committee
(approval L-07-010). All experiments involving the
marmoset monkey were conducted in accordance with
the Australian Code of Practice for the Care and Use of
Animals for Scientiﬁc Purposes and were approved by the
Monash University Animal Ethics Committee, which also
monitored the welfare of these animals
Preparation of mice primary astrocyte cell culture
Mix glia culture was prepared from the cerebral cortex of
10 C57BL/6 newborn (P1-P3) mice. Cortexes, from which
meninges were removed, were collected on ice in HBSS
solution (Biological industries, Israel). Following two
washes with 20ml of cold HBSS, cortexes were digested
with digestion buffer containing 0.25% trypsin (Sigma,
USA) and 100mg/ml DNase I type IV (Sigma, 1980 KU/
mg protein) in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Biological Industries) without serum. More spe-
ciﬁcally, 5ml digestion buffer per 10 cortexes was used for
two to three times of pipetation followed by addition of
10ml digestion buffer and incubated for 5min at room
temperature. Fifteen milliliters of cold DMEM containing
10% heat inactivated fetal calf serum (HIFCS) were then
added to stop tissue digestion followed by ﬁltration
through 100mm nylon membrane (A.D.Sinon, Israel)
into a new 50-ml tube. After centrifugation at
1100r.p.m. for 10min at 4 C, the supernatant was
aspirated and the cells were resuspended in warm 10ml
DMEM containing 10% HIFCS. Following a second ﬁl-
tration of the cells through 100mm nylon membrane, the
cells were counted in the presence of trypan blue to assess
the amount of live cells. Cells were seeded on T75cm
2
ﬂasks or 150mm plates pre-coated with 10mg/ml
Poly-L-lysine (Sigma) at a density of  3.8 10
6 live cells
per ﬂask. The mixed glial cells were incubated in growth
medium containing DMEM-10% HIFCS supplemented
with 2mM L-glutamin, 100U/ml penicillin and
100mg/ml stretomycin, non-essential amino acids and
110mg/ml Na-Pyr (all from Biological Industries). The
growth medium was replaced at Day 2 and Day 7 after
plating. To enrich the mixed glia culture with astrocytes,
at Day 13 the ﬂasks were shaken on an orbital shaker at
150r.p.m. for 18h, to discard microglia and oligodendro-
cytes attached at the upper layer of the astrocytes culture.
After shaking, the remaining astrocytes were trypsinized
and further plated on 10-cm plates at a density of 1 10
6
cells per plate.
Preparation of marmoset primary astrocyte cell culture
Primary astrocyte cultures were derived from the ablated
area of PD14 marmoset (Callithrix jacchus) primary visual
cortex. Meninges were removed and the tissue was mech-
anically dissociated using a scalpel blade in minimal essen-
tial media (MEM) (Gibco, USA). Tissue was then
incubated for 20min in Solution C (476mg HEPES,
40mg EDTA, 50mg trypsin and 2ml of 1mg/ml DNase
I in 200ml of calcium and magnesium free heparin-
buffered saline solution, adjusted to pH 7.6, ﬁltered-
sterilized and stored in  20 C), followed by the addition
of an equal volume of Solution A (14mg of trypsin inhibi-
tor, 1ml of 1mg/ml DNase I dissolved in 100ml MEM,
ﬁltered-sterilized and stored in  20 C). After 1min, the
cell suspension was diluted using MEM (1:10), then
pelleted, resuspended in DMEM (Gibco) containing
10% FCS, 100U/ml penicillin and 100mg/ml streptomycin
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the mixed glial culture for astrocytes, ﬂasks were shaken
on an orbital shaker at 150r.p.m. for 4h. The growth
medium was replaced after the shaking process and cells
were ready to be used for experiments 1 week later.
Primary cultures were trypsinized and re-plated on poly-
D-lysine coated chamber slides (Nunc) or into 10-cm Petri
dishes (Nunc) at 1 10
4 cells/well or 1 10
6 cells/plate,
respectively.
Primary astrocyte cell culture activation and testing
Mice and marmoset astrocytes primary cultures were
treated with ﬁnal concentrations of 2mg/ml LPS (Sigma,
USA) and 3ng/ml INF-g (Roche, Switzerland) for 6, 14,
24 and 48h to induce activation. Enzyme-linked
immunoabsorbent assay (ELISA) was performed on
medium collected from mice reactive astrocytes according
to murine IL-6 and TNF-a ELISA development kit
(PeproTech, USA). Recombinant mouse IL-6 and recom-
binant mouse TNF-a (PeproTech, USA) were used for
standard curves.
Cultures purity test by ﬂuorescence-activated cell sorting
or immunostaining
Astrocytes were cultured in 10-cm plates and treated as
indicated. After incubation, mouse astrocytes were gently
removed from the tissue-culture plates by trypsin diges-
tion, then centrifuged at 1100r.p.m. for 7min at 4 C.
For microglial marker CD11b staining, cells were
incubated for 45min at 4 C in ﬂow cytometry buffer
[phosphate-buffered saline (PBS) containing 1% BSA
and 0.05% sodium azide] supplemented with PE-
conjugated anti-CD11b mAb (BioLegend, USA). For
the astrocytic marker GFAP, cells were ﬁxed with cold
methanol (–20 C) followed by three washes with ﬂow
cytometry buffer and incubation with polyclonal rabbit
anti-GFAP ab (DAKO, USA) for 1h at room tempera-
ture. Following three washes with ﬂow cytometry buffer,
cells were incubated with anti-rabbit-FITC Fab (Jackson
ImmunoResearch, UK). Antigen expression on 5000 live
cells was determined by ﬂuorescence-activated cell sorting
(FACS) analysis (FACSort; BD Biosciences, USA) and
CellQuest software (BD Biosciences).
To conﬁrm marmoset astrocyte culture purity, cell
cultured in chamber slides were ﬁxed with 4% PFA for
10min followed by permeabilization with chilled (–200 C)
methanol and blocking with Blocking Solution (PBS con-
taining 2% FCS, 2% GS) for 1h. Immunostaining was
performed using GLAST, early astrocyte marker (1:100,
abcam, USA) and CD11b, microglia marker (1:500,
Millipore, USA). Cells were incubated with primary
antibodies for 2 h, then chamber slides were washed
three times in PBS. Cells were then incubated with the
secondary antibodies, goat anti-rabbit Alexa594 and
goat anti-rat Alexa488 (1:1000, Molecular Probes, USA)
for 1h at room temperature, washed three times in PBS
and mounted with Fluoromount (DAKO, USA). The
nuclei of cells repopulating the scratched area were
visualized by 40-6-diamidino-2-phenylindole (DAPI)
(1:1000; Sigma, USA) staining.
Immunohistochemistry
Sections (40mm) were examined using standard
immunohistochemical procedures to determine expres-
sion and localization of microglia marker, CD11d, 3
weeks after brain injury in the marmoset brain (19).
Free-ﬂoating sections were incubated in PBS containing
0.3% Triton X-100 (PBS-TX) for 1h, followed by
blocking solution [PBS-TX containing 5% normal goat
serum (NGS, Invitrogen, USA)] for 1h at room
temperature. Rat anti-CD11b (1:500, Millipore, USA)
was diluted in blocking solution and incubated with
sections overnight at 4 C. Sections were then washed
three times in PBS and incubated with secondary
antibody, goat anti-rat conjugated with AlexaFluor
488 (Molecular Probes), for 2h at room temperature,
followed by three 20-min washes with PBS.
Sections were then mounted using with Fluoromount
(Dako, USA).
RNA extraction
Total RNA was extracted from astrocytes primary
cultures or C6 cells using TRIZOL reagent (Invirogen,
USA). The ﬁnal RNA concentration and purity were
measured using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Thermo Scientiﬁc, USA).
miRNA proﬁling
First-strand cDNA was synthesized from total RNA using
Megaplex reverse transcriptase reaction with the High
Capacity cDNA kit (Applied Biosystems, USA). This
reaction contains a speciﬁc stem–loop primer for each
mature target miRNA. Each stem–loop primer is
designed to hybridize to only the fully mature miRNA,
and not to precursor forms of its target. The TaqMan
Low-Density Arrays (TLDAs) are quantitative
real-time-polymerase chain reaction (RT–PCR) assays
based on Applied Biosystems technology. The mixture
for each sample, containing complementary DNA
(cDNA), RNase-free water and TaqMan Universal PCR
Master Mix (No AmpErase UNG; Applied Biosystems)
was then transferred into a loading port on Rodent TLDA
cards A and B, according to the manufacturer’s instruc-
tions. The card was centrifuged twice, sealed and PCR
ampliﬁcation was carried using ABI Prism 7900HT
Sequence Detection System under the following thermal
cycler conditions: 2min at 50 C, 10min at 95 C, 40 cycles
of (30s at 95 C and 1min at 60 C). Results were analyzed
with SDS software (Applied Biosystems) and the RQ
(relative quantity) Manager Software, for automated
data analysis. miRNA relative levels were calculated
based on the comparative threshold cycle (Ct) method.
In short, the Ct for each miRNA and endogenous
control snoRNA202 in each sample, were used to create
Ct values (CtmiRNA–Ct snoRNA202). Thereafter, Ct
values were calculated by subtracting the Ct of the
control untreated astrocytes from the Ct value of astro-
cytes 48h following activation. The RQs were calculated
using the equation: RQ=2
 Ct. In addition to P-value
calculated for the relative levels, we calculated the P-value
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and adjusted the values for multiple testing by the false
discovery rate (FDR) method of <0.05, (20). Three
miRNAs exhibited statistically signiﬁcant expression
increase while one miRNA exhibited statistically signiﬁ-
cant expression decrease (Figure 2B).
miRNA kinetics by quantitative RT–PCR
First-strand cDNA was synthesized from total RNA
using a MultiScribe reverse transcriptase reaction with
the High Capacity cDNA kit (Applied Biosystems,
USA) and TaqMan MicroRNA Assay RT primer
(Applied Biosystems) for each miRNA. Mixtures contain-
ing cDNA, RNase-free water, TaqMan Universal PCR
Master Mix (No AmpErase UNG; Applied Biosystems)
and TaqMan MicroRNA Assay Real-Time probe
(Applied Biosystems) for each miRNA were loaded on
96-well plates (Axygen Scientiﬁc, USA). PCR ampliﬁca-
tion and results analysis were done as described under
‘miRNA proﬁling’ in ‘Materials and Methods’ section
[Thermal cycler conditions: 2min at 50 C, 10min at
95 C, 40 cycles of (15s at 95 C and 1min at 60 C)],
while 6, 14, 24 and 48h of activation were compared to
untreated astrocytes to yield the RQ.
mRNA kinetics by quantitative RT–PCR
First-strand cDNA was synthesized from total RNA using
a MultiScribe reverse transcriptase reaction with the High
Capacity cDNA kit (Applied Biosystems, USA) and
random hexamer primers (Applied Biosystems).
Mixtures containing cDNA, RNase-free water, speciﬁc
primers (see ‘Primers’ in ‘Materials and Methods’
section) (Sigma, USA) and Power SYBR green PCR
master mix (Applied Biosystems), were loaded on
96-well plates (Axygen Scientiﬁc, USA). PCR ampliﬁca-
tion was done as described under ‘miRNA proﬁling’ in
‘Materials and Methods’ section (Thermal cycler condi-
tions: 2min at 50 C, 10min at 95 C, 40 cycles of (15s at
95 C and 1min at 60 C) and dissociation curve cycle of
15s at 95 C, 15s at 60 C and 15s at 95 C. The dissoci-
ation curve is required to show a united peak for all
samples, meaning that only one product was created.
Standard curve was ﬁrst created for each pair of primers
to determine proper primer concentration for linear amp-
liﬁcation. Results’ analysis was done as described under
‘miRNA proﬁling’ in ‘Materials and Methods’ section,
using GAPDH as endogenous control.
PCR primers
miRNA cluster: (i) miR-503-Fwd: CCT AGC AGC GGG
AAC AGT AC, miR-351-Rev: TAA CAC TCT TCT
CCA GTT CCC; (ii) miR-322-Fwd: GAA GGG CTG
CAG CAG CAA TT, miR-503-Rev: TAC TCC AGG
GCA CCA AAC AC. Mice gene qPCR: GAPDH-Fwd:
TGC ACC ACC AAC TGC TTA G, GAPDH-Rev: GGA
TGC AGG GAT GAT GTT C; PEA15-Fwd: TAC AGA
ACC CGT GTG CTG AA, PEA15-Rev: GGC TGC
CGG ATA ATG TCT TT; TNF-a-Fwd: TGT AGC
CCA CGT CGT AGC, TNF-a-Rev: TTG AGA TCC
ATG CCG TTG G; SIAH2-Fwd: ATG CCG CCA
GAA GTT AAG C, SIAH2-Rev: AGC CCG TGG
TAG CAT ACT TA. Marmoset gene qPCR: GAPDH-
Fwd: AAA GTG GAT GTC GTC GCC ATC AAT
GAT, GAPDA-Rev: CTG GAA GAT GGT GAT
GGG ATT TCC ATT; TNF-a-Fwd: CAG CCT CTT
CTC CTT CCT GCT, TNF-a-Rev: GCC AGA GGG
CTG ATT AGA GA; SIAH2-Fwd: GGC AGT CCT
GTT TCC CTG TA, SIAH2-Rev: CAC TTG CAG
GAA GCA CCA G; C6 cells (rat) gene qPCR:
GAPDH: as in mice. TNF-a-Fwd: GCC TCT TCT
CAT TCC TGC TC, TNF-a-Rev: GAG CCC ATT
TGG GAA CTT CT; SIAH2-Fwd: ATG CCG CCA
GAA GTT GAG C, SIAH2-Rev: AGC CCG TGG
TGG CAT ACT TA.
30 UTR constructs
Fragments of 700bp of TNF-a, 500bp of SIAH2 and
400bp of PEA15 30 UTR spanning the miRNAs binding
sites were cloned into the XhoI–NotI restriction site
downstream to the Renilla Luciferase Reporter of the
psiCHECK
TM
-2 plasmid (Promega, USA) that contain a
Fireﬂy Luciferase Reporter (used as control) under a dif-
ferent promoter. For this purpose, the 30 UTR fragments
were PCR-ampliﬁed from mice brain cDNA and XhoI–
NotI restriction sites were added (italics), using the
primers: TNF-a-Fwd: ACA CTC GAG CCC TTT ATT
GTC TAC TCC TCA; TNF-a-Rev: AAG GTC AAG
CGG CCG CCA ATG ACC CGT AGG GCG ATT;
SIAH2-Fwd: ACA CTC GAG TCG GTG ATC TCA
AAA TCA ACT C; SIAH2-Rev: AAG GTC AAG CGG
CCG CCA AGG GAA GCC ATA TGT AAA C;
PEA15-Fwd: ACA CTC GAG CGT GCT AAC TGT
GTG TGT ACA T; PEA15-Rev: AAG GTC AAG CGG
CCG CAA GGC AGG TGT CTG CAG CA; The
miRNA-binding sites were site-directed mutated by PCR
reaction of the plasmid using the enzyme PfuUltra II
Fusion HS DNA Polymerase (Genex, USA), and the
PCR reaction: (i) 95 C for 2 min, (ii) (95 C for 20s,
58 C for 20s, 72 C for 2min) X16, (iii) 72 C for 3min.
The primers used for mutagenesis were the ones indicated
below (target nucleotides in italics) and complementary
Reverse primers: TNF-a-351-(miR-351 binding site)-
Fwd: AGG GGA TTA TGG CTC CTA TTC AAC
TCT GTG CTC; TNF-a-298-Fwd: TAC ATC ACT
GAA CCT AAC ATC CCC ACG GGA GCC G;
SIAH2-351-Fwd: CTT GAC AGA TCG CTC CTA
TCT GCC TCC CCC TGC C; SIAH2-298-Fwd: GCT
TTA AGG CGT CCT AAC ATG ACA CTG TTG
GTC T; PEA15-155-Fwd: TTT GTG GTT TTT AGC
CGC GAC TTA TTG TCT AGG C. Products were then
incubated with DPN1 (New England BioLabs, UK) that
digest the methylated source plasmid and the mutated
plasmid was sequenced.
miRNA constructs
Pre-miRNAs were cloned into the BamI–EcoRI restric-
tion site of the miRNA expression vector miRVec that
was provided by Prof. R. Agami (21). For this purpose,
the genomic loci of  200bp upstream and downstream of
the pre-miRNAs was PCR-ampliﬁed from mice tail
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striction sites were added (italics), using the primers:
miR-351-Fwd: GCG GAT CCA GGT GGT ACA ATG
AGA GGC A; miR-351-Rev: GCG AAT TCA GGC CTC
CTC TAA CTG TAC C; miR-298-Fwd: GCG GAT CCC
TCTT TGT GCT ACT ACA TG; miR-298-Rev: GCG
AAT TCC ACT GCA TCG ACA ATG GGA A;
miR-155-Fwd: GCG GAT CCG GAT TTA ATG AGC
TCC TTC CTT TCA AC; miR-155-Rev: GCG AAT
TCC TAA ATG CAA ACA TTT TCA TTT AAA TG.
Dual Luciferase assay
HEK293 cells were seeded in 24-well plates in DMEM
supplemented with 10% FBS and 1% Pen/Strep. Cells
were transfected using theTransIT-LT1 Transfection
Reagent (Mirus, USA), according to the manufacturer’s
instructions, with 500ng DNA: 5ng psiCHECK
TM
-2 con-
taining the desired 30 UTR with or without site-directed
mutations; 10ng GFP vector and 485ng miRVec contain-
ing the desired pre-miRNA or an empty vector.
Forty-eight hours after transfection, the transfection efﬁ-
ciency was measured by green ﬂuorescent protein (GFP)
ﬂuorescence, indicating a transfection efﬁciency of  50%
repeatedly, and ﬁreﬂy and Renilla Luciferase activities
were measured using the Dual-Luciferase Reporter
Assay System kit (Promega, USA) and a Veritas
microplate luminometer (Promega), according to
Promega’s instructions.
C6 astrocytoma cells activation and miRNA manipulation
C6 cells were seeded in six-well plates in DMEM supple-
mented with 10% FBS and 1% Pen/Strep. Transfections
were done using Lipofectamine 2000 transfection reagent
(Invitrogen, USA) according to the manufacturer’s in-
structions. Transfection efﬁciencies were measured by
GFP ﬂuorescence in C6 cells, indicating a transfection ef-
ﬁciency of  50% repeatedly. For activation, 24h after
seeding, cells were starved from FBS for 12h prior to
treatment with LPS (2mg/ml) and IFN-g (3ng/ml) for
18h. For miRNA over-expression, 24h after seeding,
transfection was done with 2.5ug miRVec containing the
desire pre-miRNA (or an empty vector). Cells were either
taken for RNA puriﬁcation after 27h or were starved after
21h following by activation for 18h. For miRNA inhib-
ition, transfection was done with 70pmol Anti-miR
miRNA Inhibitors or a scrambled inhibitor (Ambion
Applied Biosystems, USA). Cells were taken for RNA
puriﬁcation 24h later.
Statistics
P-values were calculated using a paired/unpaired t-test or
Chi-square test.
RESULTS
The involvement of miRNAs in astrocyte activation
Several studies have addressed the changes in gene expres-
sion following activation of astrocytes with LPS and/or
INF-g (22–24). To address the issue of miRNAs
involvement in regulation of gene expression during astro-
cyte activation, we isolated astrocytic cells from cerebral
cortex of newborn C57BL/6 mice, and exposed the
primary cultures to LPS and INF-g (see ‘Materials and
Methods’ section). The purity of the cultures was
determined by ﬂow cytometry analysis that showed over
90% GFAP-positive cells (and  95% CD11b-negative
cells), representing astrocytes (Supplementary Figure 1).
The activation process was accompanied by a steady
increase in secretion of interleukin 6 (IL-6) and TNF-a
as measured in the medium at 6–48h following LPS and
INF-g application (Figure 1), consistent with previous
reports (2,25). In an effort to understand the complete
network of gene interactions during astrocyte activation,
we performed global analysis of miRNA expression in
astrocytes treated with LPS and INF-g for 48h
compared to untreated astrocytes (The full table is avail-
able in Supplementary Table 1). We found that resting
astrocytes highly express a set of miRNAs, among which
are miR-26a and miR-29a, previously shown to be
abundant in this cell type (26) (Supplementary Table 2).
Analysis of the differentially expressed miRNAs in treated
and untreated astrocytes revealed a signiﬁcant alteration
in the expression levels of several miRNAs, enabling the
deﬁnition of a distinct miRNA expression signature upon
LPS and INF-g-induced activation (Figure 2). This obser-
vation suggests that some miRNAs play a role in the gene
regulatory networks following astrocyte activation.
The mouse and rat-speciﬁc miR-351 is transcribed as part
of a conserved miRNA cluster
In any given cellular process, out of the entire miRNA rep-
ertoire, usually only a few miRNAs show differential ex-
pression. Similarly, in our experiments, most miRNAs did
not exhibit differential expression in treated versus non-
treated astrocytes (Figure 2A). However, 12 miRNAs ex-
hibited increased expression of more than 2-fold following
activation (P<0.033) while the expression of six miRNAs
decreased more than 3-fold (P<0.01). These miRNAs
were considered for further analysis (see ‘Materials
and Methods’ section for further statistical analysis by
false discovery rate). Selected miRNAs are presented in
Figure 2B. Among the upregulated miRNAs, we
observed several, including miR-155, miR-146a/b and
Figure 1. Astrocyte activation by LPS and IFN-g. IL-6 (A) and TNF-a
(B) secretion into the medium detected by ELISA following 6h, 14h,
24h and 48h of LPS (2mg/ml) and IFN-g (3ng/ml) treatment of mice
astrocytes demonstrates the biological activity of astrogliosis. Note that
neither IL-6 (A) nor TNF-a (B) cytokines were secreted from untreated
astrocytes, while their secretion was dramatically increased during the
LPS and INF-g treatment. Values represent mean levels±SEM
(N=4). P<2e-05 for all bars compared to untreated astrocytes.
3714 Nucleic Acids Research, 2011,Vol.39, No. 9miR-147, that were previously shown to be induced in
diverse immunological-related cellular systems, such as
monocytes and macrophages, upon LPS or IFN-g treat-
ment (Table 1; and references within). This indicates a
global inter-cellular response among astrocytes and
immune cells. Interestingly, two of the mostly suppressed
miRNAs in reactive astrocytes, miR-351 and miR-298, are
reportedtobespeciﬁctomiceandrats(seemiRbase:http://
www.mirbase.org). ThemiR-351geneisfoundonlyinmice
and rats (Figure 3A). Additional miRNA gene identifying
algorithms could not locate miR-351 gene in any other
animal (see miRNAminer: http://groups.csail.mit.edu/
pag/mirnaminer and miRviewer: http://
people.csail.mit.edu/artzi/miRviewer). miR-351 belongs
to the miR-125 family, shown to perform varied roles in
development, cancer and inﬂammation (27–30) (Figure
3B). Members of a miRNA family share the regulatory
‘seed’ region, dictating their targeting. The fact that some
members of the miR-125 family potentially regulate the
same target genes while they are species speciﬁc raises the
question if these miRNA genes evolved independently to
take up species-speciﬁc functions. To address this question,
we chose to compare miR-351 to other members of the
miR-125 family on the level of: (i) genomic loci; (ii) expres-
sion levels; and (iii) gene targets. In mice and rats, miR-351
resides within a well-conserved miRNA cluster
(Figure 3C). It appears that all the expressed miRNAs
in this cluster are downregulated 48h following astrocyte
activation, suggesting that they are all controlled under a
common transcriptional unit (Figure 3C). Using primers
complementary to the pre-miRNAs sequences of the
mice miR-351, miR-503 and miR-322, we could amplify
by RT–PCR the region transcribed upstream to miR-351
and thus conﬁrmed that miR-351 is transcribed into a large
transcript which can harbor at least part of the miRNA
cluster (Figure 3D). For comparison, other members
of the miR-125 family in mice are located either solely
in introns (miR-125b-1 and -2) or in a miRNA cluster
(miR-125a; together with miR-99b and let-7e). The
second mouse and rat-speciﬁc miRNA, miR-298, possesses
a different mature sequence in mice and rats, including the
seed region, compared to that of primates (Figure 3A). For
this reason miR-298 is hereafter termed miR-298.mr to
indicate its mouse and rat-speciﬁc seed region [as in
TargetScan (8)]. As a consequence, this miRNA targets a
different set of genes in mice and rats compared to
primates, thus probably having a different regulatory
function. We note that this assumption is based on
‘seed’-related computational predictions only (31–34)
while other targeting rules exist (35).
miR-351 and miR-125b expression levels are
complementary in rodents and primates
Activation of macrophages and dendritic cells via
exposure to LPS and IFN-g elicits an innate immune
Figure 2. miRNA expression signature following astrocyte activation
in mice. Mice cortical astrocytes primary cultures were incubated
with LPS and IFN-g (2mg/ml and 3ng/ml, respectively). Following
48h total RNA was puriﬁed and miRNA levels were assayed on a
high-throughput quantitative real-time PCR array. (A) Scatter-plot rep-
resentation of the distribution of miRNAs expressed in treated astro-
cytes compared with those from untreated cultures. Values are
presented as 1/threshold-cycle (1/ct) mean (N=3). miRNAs with
ct 40 (0.025 on this graph) were not taken into consideration.
miRNAs that are deviating from the linear regression line by at least
15% (up) or 8% (down) are indicated. (B) Relative Quantiﬁcation (RQ)
(Log(2
^-ct)) of selected miRNAs. Comparison was made to a
non-related small non-coding RNA (snoRNA202) and to untreated
astrocytes. Values are presented as mean±SEM (N=3, each repeat
containing a mixture of at least two independent cultures, P<0.033).
miRNAs with a statistically signiﬁcant differential expression (unpaired
t-test adjusted for multiple testing by FDR of <0.05, see ‘Materials and
Methods’ section) are marked with an asterisk.
Table 1. Selected miRNAs modiﬁed expression in diverse LPS/IFN-g-treated systems and in our experiments
miRNA Organism Activation system Direction Time
a (h) Ref. Astrocytes RQ
b – our study
miR-146a Human Monocytes (LPS) Activation 8 (63,64) 14.4
miR-155 Mouse Macrophages (LPS) Activation 48 (65) 13.2
Human Monocytes (LPS) Activation 8 (63,64) 13.2
Mouse Macrophages (IFN-g) Activation 24 (66) 13.2
miR-146b Human Monocytes (LPS) Activation 8 (63,64) 8.0
Human Leukocytes (in vivo, LPS) Suppression 4 (67) 8.0
miR-147 Mouse Macrophages (LPS) Activation 24 (68) 5.7
miR-222 Human Monocytes (LPS) Activation 8 (64) 2.2
miR-142-3p Mouse Lungs (in vivo, LPS) Activation 6 (69) 2.2
aLatest time tested in which the observed expression was apparent.
bRelative Quantiﬁcation (2
^-ct) from our experiments compared to small RNA control and untreated astrocytes (N=3, P<0.033).
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in gene expression (36,37). We have shown that miRNA
expression is changed under similar conditions in brain
astrocytes as well. Assuming that this response is
conserved among various organisms, it was surprising
that miR-351 and miR-298.mr, tagged as possible import-
ant regulators, were found to be species speciﬁc. We
hypothesized that if miR-351 was indeed functional then
its expression level would mimic that of its other family
members from different organisms. To test this hypoth-
esis, we compared the expression pattern of the miRNAs
mostly altered in our data in mice and primates following
astrocyte activation. For this purpose, we generated
primary astrocyte cultures from visual cortex of PD14
marmoset (C. jacchus). The marmoset astrocyte cultures’
purity was determined by Immunostaining with the micro-
glia marker CD11b and the astrocyte marker GLAST (38)
that showed a total purity for astrocytes (Supplementary
Figure 2A). LPS- and INF-g-induced activation in these
cultures was accompanied by induction of IL-6 and
TNF-a mRNA levels (Supplementary Figure 2B).
Following treatment of the mice and marmoset astrocytes
with LPS and INF-g, we monitored the expression level of
the miRNAs along a continuous time course. The expres-
sion level of the conserved miRNAs, miR-155 and
miR-146a, gradually increased in both species from 6
through 14 and 24h after treatment, reaching their
maximum levels at 48h (Figure 4). While miR-155
upregulation was more prominent in mice, miR-146a
upregulation was stronger in marmoset. The expression
of other conserved miRNAs, miR-149 and miR-455, grad-
ually decreased in both mice and marmoset while, inter-
estingly, the expression of the mouse and rat-speciﬁc
miR-298.mr was also gradually downregulated. The ex-
pression of the second mouse and rat-speciﬁc miRNA,
miR-351, was downregulated in mice (reduced by 54%
at 24h after treatment), similarly to its family member
miR-125b, which was downregulated in marmoset (by
Figure 3. The evolution of miR-351 and miR-298.mr. (A) Evolutionary conservation of miR-351 and miR-298. Images are reproduced from
miRviewer (http://people.csail.mit.edu/artzi/miRviewer). miR-351 and miR-298.mr are unique to mice (mmu – Mus musculus) and rats (rno –
Rattus norvegicus). Bolded nucleotides represent the mature miRNA. Nucleotide variations are italicized and underlined. (B) Alignment of
mature miRNA sequences from the miR-125 family (cel – Caenorhabditis elegans). Bolded nucleotides represent the regulatory ‘seed’ region
which is identical to all family members. (C) An on-scale representative of the genomic locus of the mouse miR-351 gene. Arrows indicate
downregulation of the miRNA expression level 48h following activation to the level indicated (mean±SEM, N=3). miR-450a-1 and 2 could
not be distinguished. ND – not detected. All miRNAs genes in this cluster, except for miR-351 gene are evolutionarily highly conserved as can be
seen in the conservation plot below (reproduced from UCSC Genome Browser). (D) Reverse transcription PCR of the RNA transcript precursor of
miR-351. Using primers complementary to the pre-miRNAs sequences of the mice miR-351, miR-503 and miR-322 that were designed to amplify the
regions indicated in (C), we observed that miR-351 gene is transcribed in a single transcriptional unit together with miR-503 (a) which is transcribed
together with miR-322 (b). Bands can be observed in cDNA and genomic DNA (gDNA) ampliﬁcation but not in RNA (to exclude gDNA
contamination).
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miR-125b did not signiﬁcantly change in mice, whereas
miR-351 does not exist in marmoset. Given that
miR-125b was implicated in other inﬂammatory systems
such as macrophage activation (28,39,40), skin inﬂamma-
tion (41) and, recently, IL-6-induced astrocyte activation
(42), these data suggest that miR-351 in rodents may have
some overlapping regulatory roles to miR-125b in
primates. Taken together, these results implicate that the
mice and rat-speciﬁc miR-351 and miR-298.mr may have
a functional signiﬁcance during astrocyte activation and
that miR-351 might have overtaken miR-125b roles.
Mouse and rat-speciﬁc miRNAs target genes associated
with the TNF-a signaling pathway
miRNAs exert their effect by binding to mRNA se-
quences. The most common mode of target identiﬁcation
is based on sequence complementary and target site con-
servation. We employed one such tool, TatgetScan (8), for
predicting targets of the miRNAs that were most signiﬁ-
cantly changed after activation. Given that the TNF-a
signaling pathway is a major player in immune responses
as well as in CNS diseases we ﬁrst asked whether this
pathway can be targeted by miRNAs in activated astro-
cytes. We searched for targets of miR-155 that are
decreased in mice activated astrocytes and that were pre-
viously shown to regulate TNF-a signaling pathway.
PEA15, that diverts astrocytes from TNF-a-triggered
apoptosis by regulating ERK/MAPK cascade action and
blocking caspase recruitment by FADD (43,44), was
among TNF-a-related genes predicted with high conﬁ-
dence to be regulated by miR-155. PEA15 mRNA expres-
sion kinetics was inversely correlated to that of miR-155,
suggesting an inhibitory regulatory relationship with this
miRNA (Figure 5A).
Given that miR-351 and miR-298.mr are speciﬁc to
mice and rats, we screened the predicted target genes of
either of these miRNAs to the ones possessing the
miRNA-binding site in both mice and rats. Interestingly,
miR-351 and miR-298.mr have more common targets
than expected by chance (312, 253, respectively,
P=1.7E-54,  
2-test), which may suggest a common
regulatory function for these miRNAs. Such a signiﬁcant
phenomenon was also apparent in a conservative method
of looking at evolutionary conserved targets only
(22 common targets, 10 expected, P=4E-4, Chi-square
test). This common target gene list is highly enriched
with brain over-expressed genes [ 60%, P=5E-16,
‘UP_Tissue’, DAVID Bioinformatics Resources (45)], sug-
gesting that the common function of miR-351 and
miR-298.mr is predominantly in the brain.
We searched for miR-351 and miR-298.mr common
targets that are known to regulate TNF-a signaling
pathway. Among these, we found TNF-a itself. This
gene 30-UTR possesses three evolutionary conserved
binding sites for miRNAs regulated by >2.5-fold 48h fol-
lowing astrocyte activation. Remarkably, these three
miRNAs, miR-351, miR-298.mr and miR-149, are the
three most downregulated miRNAs in mice astrocyte ac-
tivation according to our expression proﬁling (Figure 2).
As mentioned, miR-298.mr and miR-351 are mouse and
rat-speciﬁc and while the TNF-a 30 UTR binding site for
miR-298.mr is conserved among most species, miR-351/
125b binding site is found in mice but not in primates or
rats so the parallel downregulation of miR-125b in
marmoset will have no effect on TNF-a. Thus, TNF-a is
predicted to be regulated by miRNAs profoundly in mice
and rats astrocytes, which may be attributed to keeping
TNF-a mRNA increase following mice astrocyte activa-
tion compared to marmoset ( 55-fold and  1-fold, re-
spectively, 14h following activation) (Figure 5A).
Among predicted targets of both miR-351 and
miR-298.mr the E3 ubiquitin–protein ligase SIAH2
(seven in absentia 2) stands out. SIAH2 mediates
TNF-a-induced ubiquitylation and degradation of
TRAF2 (46). Similar to the TNF-a 30 UTR, SIAH2
binding site for miR-298.mr is conserved among most
species while miR-351/125b binding site is not found in
primates. This suggests that the TNF-a signaling pathway
may be profoundly regulated by miRNAs in mice and rats
Figure 4. Mice and monkey miRNAs expression following astrocyte
activation by LPS and INF-g. Astrocytes primary cultures from mice
and marmoset were incubated with LPS and IFN-g for 6, 14, 24 and
48h. The RNA was puriﬁed and miRNA levels were measured by
quantitative real-time PCR. Black/gray plots represent mice/marmoset
miRNAs, respectively. miR-351 plot is dashed. Values are presented as
miRNA Relative Quantiﬁcation (2
^ ct) levels compared to
non-coding RNA control (snoRNA202) and untreated astrocytes.
Values are presented as mean±SEM (N=4). Marmoset miR-125b
expression is marked by asterisk where P<0.03.
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regulation by miRNAs may be attributed to maintaining
SIAH2 mRNA at high levels following mice astrocyte ac-
tivation compared to marmoset ( 1.7- and  0.6-fold, re-
spectively, 14h following activation) (Figure 5).
In order to validate these miRNA predicted targets, we
ﬁrst tested the direct interaction for the miRNA-target
pairs. We employed the Luciferase reporter assay.
Target genes 30-UTRs spanning the miRNA-binding
sites were cloned downstream to a Renilla Luciferase
reporter gene. Reporter plasmids and miRNAs were
cotransfected into HEK293 cells. Relative expression of
the Renilla Luciferase reporter was measured compared
to a Fireﬂy Luciferase reporter, a control transfection
and the 30UTRs mutated in the miRNA binding site (see
‘Materials and Methods’ section and Figure 5C). Both
miR-351 and miR-298.mr signiﬁcantly reduced the
Renilla Luciferase-TNF-a activity to 82–87% compared
to a control plasmid (Figure 5B). Similar results were
obtained when using SIAH2 30UTR but to a larger
extent: both miR-351 and miR-298.mr reduced the
Luciferase activity to 32–44%. Interestingly, when
cotransfecting the two miRNAs together (the total
amount of the miRNAs was maintained at constant
levels), a larger reduction of the Luciferase activity was
observed. This suggests a synergistic function of
miR-351 and miR-298.mr when regulating SIAH2.
Similarly, PEA15 30 UTR was affected by miR-155.
In order to further test miR-351 and miR-298.mr regu-
lation upon TNF-a and SIAH2 in astrocyte activation, we
employed the rat astrocytoma C6 cell line, which is used as
a model of astrocytes and their activation (e.g., see refs. 47
and 48). Since C6 are rat derived cells, while our primary
cultures are mouse-derived, we should note that TNF-a
30-UTR possesses a binding site for miR-298.mr and
miR-351 in mice but only for miR-298.mr in rats.
SIAH2 possesses binding sites for both miRNAs in mice
and rats. We ﬁrst activated C6 cells with the same levels of
LPS and INF-g that were used for the primary cultures
(see ‘Materials and Methods’ section and ref. 49). The
activation was accompanied with TNF-a increase and
with miR-351 and miR-298.mr decrease in accordance
with activation of mice cultured astrocytes (Figure 6A).
We then over-expressed miR-298.mr prior to activation
Figure 5. TNF-a signaling pathway related genes 30-UTRs are modulated by miRNAs. (A) Astrocytes primary cultures were incubated with LPS
and IFN-g for 6, 14, 24 and 48h. Following RNA puriﬁcation mRNA levels were measured by quantitative real-time PCR. Values are presented as
levels of mRNA relative quantiﬁcation (2
^-ct), or [Log(2
^-ct)], compared to controls (GAPDH) and untreated astrocytes, as mean±SEM
(N=4). Black/gray plots represent mice/marmoset mRNA, respectively. (B) Predicted targets 30-UTRs spanning miRNAs binding sites were
cloned to the psiCHECK-2 plasmid downstream to a Renilla luciferase reporter gene. This plasmid (or its mutated version) was cotransfected
along with a plasmid containing the correlated pre-miRNA to HEK293 cells. Renilla luciferase activity was measured 48h following transfections
and normalized to Fireﬂy luciferase activity and transfections with control plasmid instead of a miRNA. Values are presented as mean±SEM
(N>3) with a P<0.003 (single asterisk) or 0.03 (double asterisk). (C) Representation of miRNA–mRNA interactions tested in the Luciferase assay,
including the mutations generated in the miRNA-binding sites.
3718 Nucleic Acids Research, 2011,Vol.39, No. 9which resulted in a reduction of TNF-a increase.
miR-298.mr and miR-351 over-expression prior to activa-
tion also reduced SIAH2 levels (Supplementary
Figure S3). In addition, TNF-a was reduced by over-
expression of miR-298.mr without activation, while
SIAH2 levels were reduced by both miRNAs in the
same conditions (Figure 6B). Finally we inhibited
miR-298.mr and miR-351 endogenous expression levels
(between 26% and 35%) resulting in TNF-a (by
miR-298.mr inhibition) and SIAH2 (by both miRNA in-
hibition) increase (Figure 6C). Altogether, we have shown
that key miRNAs in activated astrocytes, speciﬁc to
mouse and rat, target genes associated with the TNF-a
signaling pathway.
DISCUSSION
A controlled reaction to trauma has proven fundamental
for the CNS (25). Given that astrocytes are vital players in
brain homeostasis, it is of importance to understand the
involvement of miRNAs in their activation which may
lead to enhanced CNS recovery. In this work, we have
demonstrated a global shift in miRNA expression in astro-
cytes treated with LPS and IFN-g. Among the signiﬁcant-
ly altered miRNAs, several possess key roles in the
response of immunological systems such as monocytes
and macrophages to bacterial and/or cytokine stimulation
(Table 1), thus suggesting that cellular pathways common
for astrocytes and cells of the immune system are actively
monitored by overlapping miRNA regulation.
We found that two of the most downregulated miRNAs
following astrocyte activation in mice are found in mouse
and rat species exclusively, implying a unique mode of
regulation for these species in CNS innate immunity.
The miR-351 gene was shown to be involved in immune
responses as it is able to attenuate viral replication (50)
while its family member, the primate miR-125b is induced
by IL-6 in human astrocytes (42), contradicting its repres-
sion by LPS and IFN-g. The mouse and rat version of
miR-298 was shown to be upregulated in the hippocampus
and blood of rats with ischemic stroke, intracerebral hem-
orrhage and kainate seizures (51) as well as in rat brains of
transient focal ischemia (52). The caveat of these studies is
in their heterogeneous cell population. We, on the other
hand, show a strong reduction of miR-298.mr in puriﬁed
mice activated astrocytes. Other studies addressed
miR-298.mr function (53,54), yet none have addressed
its diverse function in different species.
We have generated a list of all mouse and rat-speciﬁc
miRNAs (37 in total, Supplementary Table S3). The genes
of 36 out of these are found in mice and rats only
(including miR-351), while miR-298.mr has undergone
mutations in the seed region, thus very likely altering its
target gene pool (mirBase, miRviewer and TargetScan).
While mRNAs are under selective pressure to maintain
7-nt sites matching miRNAs (55), miRNA predicted
gene targets are considered more reliable when the
miRNA-binding site is evolutionary conserved and thus
can be predicted above the background of false-positive
predictions (8). The upper 10 percentiles of miRNAs have
more than 450 predicted targets with conserved binding
sites (6), while mouse and rat-speciﬁc miRNAs have a
relatively low number of these (201, TargetScan). This is
not surprising given an ancient co-evolution for conserved
miRNAs and their targets (6) and the lack of such a
process in the case of species-speciﬁc emergence of a
miRNA. Thus, evolutionary conserved miRNAs may
have developed more prominent regulatory roles and
have attracted much more attention so far compared to
very few studies addressing species-speciﬁc miRNAs.
miR-351, however, stands out as having many conserved
Figure 6. TNF-a and SIAH2 expression is regulated by miR-351 and
miR-298.mr in C6 astrocytoma cells. (A) C6 cells were treated with
2mg/ml LPS and 3ng/ml INF-g for 18h (Act., Activation) with or
without initial over-expression (OE) of miR-298.mr (or a control
plasmid). Following RNA puriﬁcation, miRNA or mRNA levels were
measured by quantitative real-time PCR. Values are presented as levels
of relative quantiﬁcation (2
^-ct) compared to controls (non-coding
RNA snoRNA202 or GAPDH) and non-activated cells. (B) miR-351
and miR-298.mr were over-expressed in C6 cells for 27h. mRNA levels
were measured as in (A). Control wells were transfected with an empty
vector control plasmid. (C) miR-351 and miR-298.mr expression was
inhibited in C6 cells for 24h. mRNA levels were measured as in (A).
Control wells were transfected with a scrambled inhibitor. All values
are presented as mean±SEM (N 3) with a P<0.05 (asterisk).
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rat-speciﬁc miRNAs (including miR-291a-3p, miR-294
and miR-295), which have 3.1-fold more conserved
targets than the average of their type (P=1.0E-4 accord-
ing to TargetScan, Figure 7A and Supplementary
Table 3). Each of these four miRNAs is part of a
conserved miRNA family in which all members share
their functional seed region and thus gene targets.
miR-351 belongs to the miR-125 family which originates
at the ﬁrst identiﬁed miRNA, lin-4 (56). Thus, miR-351
may regulate the genes that have developed as targets for
other more ancient family members and thus seem to hold
prominent roles in mice and rats (Figure 7B). miR-298.mr
does not belong to a miRNA family, yet we notice that the
region spanning its binding sites on many of the 30-UTRs
are exceptionally well conserved. This may be due to
another role played by these sequences and requires
their conservation. miR-298.mr may have evolved its regu-
lation upon these conserved regions and consequently
allowed the generation of many targets for this mouse
and rat-speciﬁc miRNA with no family members.
New miRNA genes may penetrate polycistronic
miRNA clusters or preferentially introns of transcribed
genes (6). We show that miR-351 is located in a well-
conserved miRNA cluster on chromosome X of mice
and rats and is transcribed as a polycistron with at least
some of the miRNAs in this cluster. All expressed
members of this cluster are downregulated following
astrocyte activation, implying a transcriptional repression
rather than downstream regulation. Thus, miR-351 util-
ization of an existing transcribed unit, eliminating the
need for de novo establishment of promoter–enhancer
sequences upstream of its gene, has created a favorable
hosting environment for this miRNA expression and
function.
We chose to compare the miRNA regulatory layer in
mice-activated astrocytes to that in common marmoset
(C. jacchus). Both human and marmoset have closely
associated immunity-related genes that are divergent
from the mice ones (57). We believe that the overall regu-
latory layer of miRNAs following astrocyte activation in
mice and marmoset follows a similar path. Moreover, the
compelling data of the complementary expression of
miR-351 and miR-125b in mice and marmoset suggest a
parallel role played by these miRNAs in mice and
marmoset. This conserved miRNA expression signature
has prompted us to study the functionality of the mostly
altered miRNAs in our study.
TNF-a is upregulated in a variety of CNS diseases such
as brain trauma, ischemic injury, multiple sclerosis and
Alzheimer’s disease and has been implicated in their
pathogenesis (58). We have chosen to focus on the
TNF-a signaling pathway, which is consequently
affected. This pathway is stimulated in astrocytes by
TNF-a secretion from inﬁltrating peripheral immune
cell, microglia and astrocytes themselves, giving rise to
autocrine/paracrine stimulation of TNFR1. The FADD/
caspase-8 branch of the TNF-a signaling pathway is
illustrated in Supplementary Figure 4. miR-155 was pre-
viously shown to target the death-domain proteins FADD
and RIP, attenuating the TNF-a signaling effect, while it
was also shown to increase TNF-a production and subse-
quently enhance signaling (28), exhibiting a complex regu-
lation for this pathway. We have validated an additional
Figure 7. The evolutionary acquisition of miR-351 conserved gene targets. (A) A box plot representing the number of conserved binding sites for
mouse and rat-speciﬁc miRNAs according to two independent target prediction algorithms: TargetScan and PITA (http://genie.weizmann.ac.il/pubs/
mir07/mir07_data.html). Intuitively, and not surprisingly, out of these miRNAs, the ones that belong to a well-conserved miRNA family have many
more conserved targets (see list of these miRNAs in Supplementary Table S3). (B) A simpliﬁed representation of miR-125 gene family evolution.
miR-125, initially titled lin-4, was ﬁrst identiﬁed in C. elegans. miR-351 has probably evolved from one of its family members, somewhere along mice
and rats common ancestors (asterisk). Given that all members of miR-125 family possess the same seed region, they are predicted to share the same
target genes.
3720 Nucleic Acids Research, 2011,Vol.39, No. 9target for miR-155 in this pathway, the death-domain
protein, PEA15 which protects astrocytes from
TNF-a-induced apoptosis (59).
The 30-UTR of TNF-a was implicated in its biogenesis
(60) long ago. The AU-rich elements (AREs) present in its
30-UTR were shown to affect TNF-a mRNA stability and
the protein translation through miRNAs and
miRNA-related proteins (61,62). The TNF-a 30-UTR
possesses conserved miRNA-binding sites outside the
AREs and miR-125b was shown to bind one of these
(28), allowing the proper production of TNF-a following
TLR ligation in macrophages. miR-125 activity was
shown to be weak in astrocytes compared to its function
in neurons (26). Given that miR-125b and miR-351 share
the same targeting speciﬁcity (namely, seed region), it did
not come as a surprise to ﬁnd that miR-351 affects the
30-UTR of TNF-a as well. We show that miR-298.mr also
targets this 30-UTR and in cooperation with miR-351
targets the TNF-a signaling pathway-related SIAH2, as
well. By over-expressing or inhibiting miR-351 and miR-
298.mr, we further demonstrated that TNF-a and SIAH2
endogenous levels in C6 cells are regulated by both
miRNAs. This implies that LPS and IFN-g-induced astro-
cyte activation in mice and rats is mediated by miRNAs
speciﬁc to these species.
Altogether, in this study, we deﬁned a miRNA regula-
tory signature following astrocyte activation. We
identiﬁed species-speciﬁc miRNAs that play key roles in
the control of this process. We revealed that these
miRNAs target genes related to the TNF-a signaling
pathway. Our study leads to a better understanding of
the mechanisms governing astrocyte activation and
presents intriguing species-speciﬁc miRNAs roles.
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